PHARMING GROUP NV - ADR (PHAR) Stock Price, Quote, News and Overview

What is the stock price of PHARMING GROUP NV - ADR today?

The current stock price of PHAR is 8.15 USD. The price increased by 0.74% in the last trading session.

What is the ticker symbol for PHARMING GROUP NV - ADR stock?

The exchange symbol of PHARMING GROUP NV - ADR is PHAR and it is listed on the Nasdaq exchange.

On which exchange is PHAR stock listed?

PHAR stock is listed on the Nasdaq exchange.

What is the price forecast or stock price prediction for PHARMING GROUP NV - ADR stock?

14 analysts have analysed PHAR and the average price target is 15.25 USD. This implies a price increase of 87.1% is expected in the next year compared to the current price of 8.15. Check the PHARMING GROUP NV - ADR stock analysts ratings, price target forecast and up-and down grades for more detailed information.

What is PHARMING GROUP NV - ADR worth?

PHARMING GROUP NV - ADR (PHAR) has a market capitalization of 557.40M USD. This makes PHAR a Small Cap stock.

How many employees does PHARMING GROUP NV - ADR have?

PHARMING GROUP NV - ADR (PHAR) currently has 382 employees.

What are the support and resistance levels for PHARMING GROUP NV - ADR (PHAR) stock?

PHARMING GROUP NV - ADR (PHAR) has a support level at 7.82 and a resistance level at 8.16. Check the full technical report for a detailed analysis of PHAR support and resistance levels.

Is PHARMING GROUP NV - ADR (PHAR) expected to grow?

The Revenue of PHARMING GROUP NV - ADR (PHAR) is expected to grow by 9.22% in the next year. Check the estimates tab for more information on the PHAR EPS, Sales, EBIT and EBITDA future analyst estimates.

Should I buy PHARMING GROUP NV - ADR (PHAR) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:

• The Technical Analysis (TA) tab contains a technical analysis of PHAR, looking at technical quality and support and resistance levels
• The Fundamental Analysis (FA) tab contains a fundamental analysis of PHAR, evaluating the profitability, health, valuation and growth aspects
• PHARMING GROUP NV - ADR (PHAR) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
• PHARMING GROUP NV - ADR (PHAR) Sales and EPS estimates to see what analysts future expectations are.
• PHARMING GROUP NV - ADR (PHAR) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
• PHARMING GROUP NV - ADR (PHAR) Insider and Institutional Ownership to learn about the owners and their transactions.
• PHARMING GROUP NV - ADR (PHAR) Stock Chart to make your own analysis
• PHARMING GROUP NV - ADR (PHAR) Latest news and press-releases to stay up to date.

Does PHARMING GROUP NV - ADR (PHAR) stock pay dividends?

PHAR does not pay a dividend.

When does PHARMING GROUP NV - ADR (PHAR) report earnings?

PHARMING GROUP NV - ADR (PHAR) will report earnings on 2025-05-08.

What is the Price/Earnings (PE) ratio of PHARMING GROUP NV - ADR (PHAR)?

PHARMING GROUP NV - ADR (PHAR) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.24).

What is the Short Interest ratio of PHARMING GROUP NV - ADR (PHAR) stock?

The outstanding short interest for PHARMING GROUP NV - ADR (PHAR) is 0% of its float. Check the ownership tab for more information on the PHAR short interest.

ChartMill assigns a fundamental rating of 4 / 10 to PHAR. The financial health of PHAR is average, but there are quite some concerns on its profitability.

Over the last trailing twelve months PHAR reported a non-GAAP Earnings per Share(EPS) of -0.24. The EPS decreased by -50% compared to the year before.

ChartMill assigns a Buy % Consensus number of 89% to PHAR. The Buy consensus is the average rating of analysts ratings from 14 analysts.

For the next year, analysts expect an EPS growth of 183.09% and a revenue growth 9.22% for PHAR